aspirin has been researched along with aspalatone in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, BH; Kang, YH; Kim, YC; Park, YH; Suh, DY; Yang, HO | 1 |
Han, BH; Kim, YC; Suh, DY; Yang, HO | 1 |
Choi, DY; Choi, JH; Jhoo, WK; Kim, C; Kim, HC; Nam, SW; Park, ES | 1 |
Han, BH; Kang, YH; Suh, DY | 1 |
Choi, DY; Jhoo, WK; Kim, C; Kim, HC; Koo, CH; Lee, DW | 1 |
Chun, IK; Gwak, HS | 1 |
Pal, PB; Ramana, KV; Shukla, K; Sonowal, H | 1 |
7 other study(ies) available for aspirin and aspalatone
Article | Year |
---|---|
Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity.
Topics: Adenosine Diphosphate; Animals; Antioxidants; Aspirin; Bleeding Time; Collagen; Fibrinolytic Agents; In Vitro Techniques; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1994 |
Metabolic fate of the new antithrombotic agent aspalatone in rats. In vivo and in vitro study.
Topics: Animals; Aspirin; Biotransformation; Chromatography, High Pressure Liquid; Dealkylation; Esterases; Fibrinolytic Agents; Humans; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Prodrugs; Rats; Rats, Sprague-Dawley; Salicylates; Spectrophotometry, Ultraviolet | 1995 |
A new antithrombotic agent, aspalatone, attenuated cardiotoxicity induced by doxorubicin in the mouse; possible involvement of antioxidant mechanism.
Topics: Animals; Antibiotics, Antineoplastic; Aspirin; Body Weight; Doxorubicin; Fibrinolytic Agents; Glutathione Peroxidase; Heart; Male; Mice; Mice, Inbred ICR; Myocardium; Oxidative Stress; Pyrones; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 1997 |
Salicylate levels in rat stomach tissues after administration of aspalatone and acetylsalicylic acid in relation to their ulcerogenicity.
Topics: Animals; Aspirin; Gastric Mucosa; Male; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Salicylates; Stomach Ulcer | 1997 |
Aspalatone, a new antiplatelet agent, attenuates the neurotoxicity induced by kainic acid in the rat.
Topics: Animals; Aspirin; Brain; Kainic Acid; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley | 1997 |
Effect of vehicles and enhancers on the in vitro skin penetration of aspalatone and its enzymatic degradation across rat skins.
Topics: Animals; Aspirin; Fibrinolytic Agents; Linoleic Acid; Male; Mice; Mice, Hairless; Pharmaceutical Vehicles; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Species Specificity | 2001 |
Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells.
Topics: Antioxidants; Aorta; Apoptosis; Aspirin; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Humans; Lipid Peroxidation; Monocytes; Signal Transduction; Vascular Endothelial Growth Factor A | 2017 |